{
"NDC": {
"NDCCode": "69238-1730-2",
"PackageDescription": "473 mL in 1 BOTTLE (69238-1730-2) ",
"NDC11Code": "69238-1730-02",
"ProductNDC": "69238-1730",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Naproxen",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Naproxen",
"DosageFormName": "SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20200803",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA212705",
"LabelerName": "Amneal Pharmaceuticals NY LLC",
"SubstanceName": "NAPROXEN",
"StrengthNumber": "25",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-12-27",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20200803",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}